Open AccessTransoral CO2 Laser‐Resection of Early Laryngeal Cancer
Author(s) -
Csanády Miklós,
Czigner Jenö,
Jóri József
Publication year - 2011
Publication title -
otolaryngology–head and neck surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.232
H-Index - 121
eISSN - 1097-6817
pISSN - 0194-5998
DOI - 10.1177/0194599811416318a136
Subject(s) - cordectomy , medicine , epiglottis , surgery , laser surgery , larynx , laryngeal neoplasm , laser , physics , optics
Objective Authors report their experience (1987‐2010) with transoral CO2 laser surgery of early glottic and supraglottic cancer. A total of 375 laser cordectomies were performed in 324 patients with Tis‐T2 vocal cord tumors, and 63 patients with T1, T2 supraglottic tumour underwent transoral supraglottic laser resection. Method Laser cordectomy of Tis (21), T1a (179), T1b (57), and T2‐3 (32) tumors and supraglottic laser resection of 40 epiglottis (36 T1, 4 T1N1), 4 vestibular fold (T1), 13 vallecula (10 T2, 3 T2N1), and 6 aryepiglottic fold (3 T2, 3 T2N1) tumors with 10 ND was evaluated. Results There was no recurrence after a single laser cordectomy in 87.5% of the patients (253/289 patients). Laser‐specific survival is 92.7% (268/289). Five‐year survival is 92.2% (214/232). “Local recurrence” was found in 36 of 289 patients (12.5%). In the supraglottic group, 47 patients are free of tumor after primary laser excision so far. Sixteen patients with local recurrence underwent salvage treatments. Late neck metastasis required 5 radical neck dissections (RND). Tumor‐free survival is 75%. Survival after salvage therapy is 98%. The voice improved during the healing. Conclusion Transoral CO2 laser surgery of the early vocal cord and supraglottic cancer proved to be a primary treatment option with success: good oncological and acceptable functional results.